<table-wrap xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="table3" position="float"><label>Table 3.</label><caption><title>The effect of mutations on the binding affinities of selected D<sub>2</sub>R ligands as determined in Tr-FRET-binding experiments.</title><p>The affinities of the fluorescently labeled spiperone derivative (Spiperone-d2) or unlabeled antagonists were determined in saturation experiments at WT or mutant SNAP-tagged D<sub>2S</sub>Rs stably expressed in FlpIn CHO cells. Binding affinity values for risperidone and eticlopride were obtained in competition binding experiments. Means of n independent experiments are shown with 95% confidence intervals (CIs).</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top"/><th colspan="3" valign="top">Spiperone-d2 <break/>saturation binding</th><th colspan="9" valign="top">&#160;Spiperone-d2&#160;competition binding</th></tr><tr><th valign="top">SNAP-D<sub>2S</sub>R</th><th valign="top"><italic>pK</italic><sub>d</sub> <break/>(<italic>K</italic><sub>d</sub>, nM) <break/>(95% CI)</th><th valign="top">N</th><th valign="top">Mut/WT</th><th valign="top">Eticlopride p<italic>K</italic><sub>i</sub> (<italic>K</italic><sub>i</sub>, nM) <break/>(95% CI)</th><th valign="top">N</th><th valign="top">Mut/WT</th><th valign="top">Risperidone p<italic>K</italic><sub>i</sub> (<italic>K</italic><sub>i</sub>, nM) <break/>(95% CI)</th><th valign="top">N</th><th valign="top">Mut/WT</th><th valign="top">Spiperone p<italic>K</italic><sub>i</sub> (<italic>K</italic><sub>i</sub>, nM) <break/>(95% CI)</th><th valign="top">N</th><th valign="top">Mut/WT</th></tr></thead><tbody><tr><td valign="top">WT</td><td valign="top">8.54 (2.88) <break/>(8.32&#8211;8.77)</td><td valign="top">9</td><td valign="top">1.0</td><td valign="top">10.06 (0.09) <break/>(9.90&#8211;10.21)</td><td valign="top">8</td><td valign="top">1.0</td><td valign="top">8.47 (3.34) <break/>(8.15&#8211;8.80)</td><td valign="top">7</td><td valign="top">1.0</td><td valign="top">9.96 (0.11) <break/>(9.76&#8211;10.18)</td><td valign="top">8</td><td valign="top">1.0</td></tr><tr><td valign="top">L94A</td><td valign="top">7.71 (19.5) <break/>(7.41&#8211;8.00)*</td><td valign="top">5</td><td valign="top">6.8</td><td valign="top">9.08 (0.83) <break/>(8.91&#8211;9.23)*</td><td valign="top">4</td><td valign="top">9.2</td><td valign="top">8.02 (9.54) <break/>(7.86&#8211;8.17)*</td><td valign="top">5</td><td valign="top">2.9</td><td valign="top">8.36 (4.37) <break/>(8.21&#8211;8.50)*</td><td valign="top">5</td><td valign="top">39.7</td></tr><tr><td valign="top">W100A</td><td valign="top">7.39 (40.7) <break/>(7.21&#8211;7.56)*</td><td valign="top">9</td><td valign="top">14.1</td><td valign="top">8.06 (8.71) <break/>(7.78&#8211;8.32)*</td><td valign="top">4</td><td valign="top">96.8</td><td valign="top">7.60 (25.1) <break/>(7.41&#8211;7.79)*</td><td valign="top">7</td><td valign="top">7.5</td><td valign="top">8.39 (4.07) <break/>(8.19&#8211;8.59)*</td><td valign="top">7</td><td valign="top">37.0</td></tr><tr><td valign="top">I184A</td><td valign="top">8.79 (1.62) <break/>(8.58&#8211;9.00)</td><td valign="top">5</td><td valign="top">0.6</td><td valign="top">9.34 (0.45) <break/>(8.94&#8211;9.75)*</td><td valign="top">4</td><td valign="top">5</td><td valign="top">9.33 (0.47) <break/>(9.18&#8211;9.48)*</td><td valign="top">5</td><td valign="top">0.1</td><td valign="top">9.78 (0.17) <break/>(9.51&#8211;10.05)</td><td valign="top">5</td><td valign="top">1.6</td></tr></tbody></table><table-wrap-foot><fn><p>*=significantly different from WT value, p&lt;0.05, one-way ANOVA with Dunnett&#8217;s post-hoc test.</p></fn></table-wrap-foot></table-wrap>